Benign Prostatic Hyperplasia (BPH)

In BPH treatment, it is important not simply to reduce the size of the prostate but to decide on the treatment method while also considering the location of the enlarged tissue, bladder function, and voiding patterns. Even with the same BPH, the cause and the pattern of obstruction differ from patient to patient, so a precise diagnosis and a customized treatment strategy can affect the outcome.

Considering these characteristics, Goldman Urology operates a stepwise BPH treatment system spanning precise diagnosis, surgical-method selection, and post-treatment care.

First, precise diagnosis of prostate size and location and any bladder dysfunction lets us analyze each patient's cause of obstruction and set the scope of treatment.Combining PSA testing, prostate ultrasound, uroflowmetry, and urodynamic studies, we diagnose by function, not just by symptoms.

Then, depending on the patient's prostate size and condition, we choose among HoLEP, Aquablation, Rezum, UroLift, iTind, and other methods and apply the right surgery or procedure.Our hallmark is a strategy built around the patient's condition, not one fixed method.

After treatment, we keep tracking voiding changes with uroflowmetry and residual-urine checks, and through a revision-surgery clinic and follow-up based on long-term clinical data, we manage both recovery and the risk of recurrence.In this way, systematically designing the whole process — cause analysis, treatment choice, and aftercare — is the hallmark of Goldman's BPH treatment.

When choosing a hospital for BPH treatment, rather than a place that applies only medication or one specific surgery, it is important to check whether it has a stepwise care system spanning accurate cause assessment, treatment selection suited to the patient's condition, and post-treatment care.This is because BPH treatment can vary depending not only on prostate size but also on location, bladder function, and voiding patterns.

Therefore, it helps to also review the following criteria.

- Whether a urology specialist provides care and a dedicated BPH clinic is available - Whether there is experience with medication, procedures, and surgery across various prostate sizes and symptom stages - Whether precise evaluations such as prostate ultrasound, PSA testing, uroflowmetry, and urodynamic studies are available - Whether systematic follow-up checks voiding improvement and recurrence after treatment

Because the right BPH treatment can differ by bladder function or obstruction location even for prostates of the same size, it is important to pinpoint the cause through precise diagnosis and set an individualized strategy before treatment.

For example, at Goldman Urology the treatment direction is set through a precise diagnostic process that checks prostate size and location and any bladder dysfunction, and among various treatment methods such as HoLEP, Waterjet (Aquablation), Rezum, UroLift, and iTind, a plan suited to the patient's condition is applied step by step.

After surgery, voiding changes are monitored with uroflowmetry and residual-urine checks, and a management plan that accounts for possible recurrence helps patients expect more stable outcomes.

The outcome of BPH surgery depends on when and how it is performed.At Goldman Urology, we focus on the following.

1. Symptom severity and quality of life: We assess how much nocturia, residual urine, and retention disrupt daily life despite medication, and whether surgery is now needed.

2. Prostate size/shape and comorbidities: We choose the surgical method (HoLEP, Aquablation, etc.) after reviewing prostate size/shape, bladder function, infection/stones, and any heart disease, diabetes, or anticoagulant use.

3. Understanding the changes after surgery: We explain in advance not only the degree of voiding improvement but also possible sexual-function changes such as retrograde ejaculation, and together decide a treatment direction that fits the patient's occupation and lifestyle.

4. Surgeon experience, equipment, and recovery: We review surgical experience, the laser equipment used, the hospitalization/recovery period, and the recurrence/complication management plan so patients can choose with peace of mind.

Whether and when it recurs depends on how completely the abnormal prostate tissue that causes BPH is removed.

· UroLift (prostatic urethral lift): The enlarged tissue is held aside with implants, not removed, so recurrence is possible.

· TURP, Plasma TURP: The immediate result is good, but due to enlarged tissue that is not completely removed, the recurrence rate is known to be about 15% at 5–10 years after surgery.

· HoLEP: Because the enlarged tissue is completely removed, recurrence is very unlikely.